Janus Henderson Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.9M | Sell |
9,437,962
-915,454
| -9% | -$8.72M | 0.04% | 281 |
|
|
2025
Q1 | $118M | Buy |
10,353,416
+2,974,107
| +40% | +$34M | 0.06% | 242 |
|
|
2024
Q4 | $174M | Buy |
7,379,309
+566,146
| +8% | +$13.3M | 0.09% | 207 |
|
|
2024
Q3 | $245M | Buy |
6,813,163
+2,189,339
| +47% | +$78.6M | 0.13% | 169 |
|
|
2024
Q2 | $163M | Buy |
4,623,824
+1,948,584
| +73% | +$68.8M | 0.09% | 197 |
|
|
2024
Q1 | $75.9M | Buy |
2,675,240
+2,663,910
| +23,512% | +$75.6M | 0.04% | 310 |
|
|
2023
Q4 | $151K | Sell |
11,330
-34
| -0.3% | -$453 | ﹤0.01% | 2486 |
|
|
2023
Q3 | $102K | Buy |
11,364
+14
| +0.1% | +$125 | ﹤0.01% | 2515 |
|
|
2023
Q2 | $128K | Buy |
11,350
+11
| +0.1% | +$124 | ﹤0.01% | 2544 |
|
|
2023
Q1 | $130K | Buy |
+11,339
| New | +$130K | ﹤0.01% | 2582 |
|
|
2022
Q4 | – | Sell |
-1,531,906
| Closed | -$19.5M | – | 2469 |
|
|
2022
Q3 | $19.5M | Buy |
1,531,906
+471,605
| +44% | +$5.99M | 0.01% | 681 |
|
|
2022
Q2 | $7.29M | Sell |
1,060,301
-122,405
| -10% | -$842K | 0.01% | 765 |
|
|
2022
Q1 | $11.4M | Buy |
1,182,706
+600,408
| +103% | +$5.78M | 0.01% | 864 |
|
|
2021
Q4 | $6.92M | Buy |
582,298
+23,815
| +4% | +$283K | ﹤0.01% | 989 |
|
|
2021
Q3 | $9.07M | Sell |
558,483
-8,683
| -2% | -$141K | ﹤0.01% | 928 |
|
|
2021
Q2 | $11.9M | Sell |
567,166
-296,908
| -34% | -$6.25M | 0.01% | 906 |
|
|
2021
Q1 | $13.4M | Buy |
864,074
+234,222
| +37% | +$3.64M | 0.01% | 850 |
|
|
2020
Q4 | $13.2M | Sell |
629,852
-356,111
| -36% | -$7.48M | 0.01% | 830 |
|
|
2020
Q3 | $19.9M | Buy |
+985,963
| New | +$19.9M | 0.01% | 710 |
|